RNF43 and colorectal adenocarcinoma: The LURE analysis of colorectal adenocarcinoma patient samples is consistent with MAPK/ERK and MAPK/JNK being the most activated pathways in both RNF43 R117fs and RNF43 G659fs in the reporter assays (Fig 4A).